RebeccaMaeAllenMDMPH
Psychiatry • Seattle, WANeuropsychiatry
Partner, Director of Research & Neuropsychiatry, Seattle Neuropsychiatric Treatment Center
Dr. Allen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Seattle Neuropsychiatric Treatment Center
805 Madison St #401
Seattle, WA 98104Phone+1 206-467-6300- Is this information wrong?
Summary
- Dr. Rebecca Allen is a psychiatrist in Seattle, WA. She received her medical degree from Oregon Health & Science University School of Medicine. She attended residency at Harvard Longwood and fellowship training at Brigham & Women's Hospital. She specializes in neuropsychiatry.
Education & Training
Beth Israel Deaconess Medical CenterChief Residency, Psychiatry, 2014 - 2015- Beth Israel Deaconess Medical CenterResidency, Psychiatry, 2011 - 2015
Brigham and Women's Hospital/Harvard Medical SchoolResidency, Psychiatry, 2011 - 2015
Oregon Health and Science University School of MedicineClass of 2011
Certifications & Licensure
WA State Medical License 2017 - 2026
MT State Medical License 2021 - 2025
ID State Medical License 2021 - 2024
MA State Medical License 2015 - 2018- American Board of Psychiatry and Neurology Psychiatry
- UCNSBehavioral Neurology and Neuropsychiatry
Awards, Honors, & Recognition
- Clinical TMS Society Service Award Clinical TMS Society, 2021
Clinical Trials
- A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression Start of enrollment: 2019 Sep 26
- Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD Start of enrollment: 2023 Feb 14
- Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD Start of enrollment: 2023 Aug 17
Publications & Presentations
PubMed
- Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report.Charles R Conway, Scott T Aaronson, Harold A Sackeim, Walter Duffy, Mary Stedman, João Quevedo, Rebecca M Allen, Patricio Riva-Posse, Matthew A Berger, Gustavo Alva, M...> ;Brain Stimulation. 2024 Apr 2
- Bilateral rTMS Shows No Advantage in Depression nor in Comorbid Depression and Anxiety: A Naturalistic Study.Scanlan, J., Gama-Chonlon, L., Allen, R.> ;The Psychiatric Quarterly. 2024 Mar 1
- 4 citationsCould bipolar depressed patients respond better to rTMS than unipolar depressed patients? A naturalistic, observational study.Larissa Gama-Chonlon, James M Scanlan, Rebecca M Allen> ;Psychiatry Research. 2022 Jun 1
- Join now to see all
Hospital Affiliations
Swedish First Hill CampusSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
